| Literature DB >> 32575742 |
Phennapha Saokham1, Kanokporn Burapapadh1, Pitsiree Praphanwittaya2, Thorsteinn Loftsson2.
Abstract
Ascorbic acid (AA) is a general antioxidant used in aqueous pharmaceutical formulations. However, in aqueous solutions, AA is unstable and easily oxidized when exposed to air, light and/or heat. Cyclodextrins are well known for their ability to form inclusion complexes with various compounds to improve their solubility and stability. Previous studies demonstrate that cyclodextrins preserve the antioxidant capacity of AA but data for γ-cyclodextrin (γCD) have not been reported. Poly(vinyl alcohol) (PVA) is a hydrophilic polymer widely used as a drug matrix in various pharmaceutical fields, but its application for drug stabilization is limited. This study aimed to investigate the protective ability of γCD on AA through the formation of ternary complexes with PVA. Binary (i.e., AA/γCD, AA/PVA and γCD/PVA) and ternary (i.e., AA/γCD/PVA) complexes were first confirmed. It was reported that those complexes were formed through interactions between the heterocyclic ring of AA, hydroxyl group of PVA and hydrophobic cavity of γCD. The hydrodynamic diameter of complexes was then studied. It was found that the diameter of γCD/PVA complexes increased with respect to the concentration of γCD. Higher γCD concentrations also resulted in increasing hydrodynamic diameters of the ternary complex. The presence of AA in ternary complexes interfered with the aggregation tendency of γCD/PVA binary complexes. Furthermore, the antioxidant capacity of AA in binary and ternary complexes was investigated. It was found that the presence of γCD preserved the antioxidant activity of AA, whereas PVA showed a contrasting effect. The influence of γCD and PVA concentration on antioxidant capacity was then studied through central composite design (CCD). Even though the concentration of γCD significantly affected the inhibition efficiency of the ternary complex, the insignificant influence of PVA could not be ignored. A promising protective ternary complex should consist of an optimized concentration of PVA and a high concentration of γCD.Entities:
Keywords: antioxidant activity; ascorbic acid; inclusion complex; poly(vinyl alcohol); γ-cyclodextrin
Mesh:
Substances:
Year: 2020 PMID: 32575742 PMCID: PMC7352738 DOI: 10.3390/ijms21124399
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Job’s plots corresponding to the ascorbic acid (AA)/ γ-cyclodextrin (γCD) (a) and AA/ Poly(vinyl alcohol) (PVA) (b) complexes at λ = 265 nm.
Band assignments of ascorbic acid (AA), γCD, and PVA in binary and ternary complexes.
| Assignment | AA | γCD | PVA | Δcm−1 | |||
|---|---|---|---|---|---|---|---|
| AA/γCD | AA/PVA | γCD/PVA | AA/γCD/PVA | ||||
| O-H stretching | - | 3260.53 | - | 45.52 | - | 60.97 | 46.15 |
| C=O stretching | 1750.80 | - | - | 10.83 | 2.69 | - | 7.76 |
| C=C stretching | 1651.54 | - | - | 37.48 | 0.63 | - | 37.46 |
| C-O stretching | - | - | 1078.72 | - | 7.90 | 1.40 | 0.77 |
Chemical shifts of ascorbic acid (AA), γCD, and PVA in binary and ternary complexes.
| Assignment | δ (ppm) | Δδ (ppm) | |||
|---|---|---|---|---|---|
| AA/γCD | AA/PVA | γCD/PVA | AA/γCD/PVA | ||
| HX | 4.8658 | −0.0073 | −0.0084 | - | −0.0144 |
| HM | 3.9977 | −0.0027 | −0.0013 | - | −0.0028 |
| HA,B | 3.6667 | −0.0018 | −0.0005 | - | −0.0013 |
| H3 | 3.8598 | −0.0030 | - | −0.0023 | −0.0022 |
| H5 | 3.7970 | −0.0027 | - | −0.0019 | −0.0018 |
| HCH2 | 1.6291 | - | 0.0003 | −0.0007 | −0.0001 |
Figure 2Stereo-chemical configuration of ascorbic acid (a), γ-cyclodextrin with internal and external protons (b), and poly(vinyl alcohol) (c).
Figure 3Hydrodynamic diameters of self-assembled γCD molecule (○) and AA/γCD inclusion complex in aqueous solutions (●).
Figure 4Hydrodynamic diameters of γCD/PVA inclusion complexes at various concentrations of γCD (○) and PVA (●).
Figure 5Hydrodynamic diameters of γCD/PVA binary complex (●) and AA/γCD/PVA ternary complex (○) at various concentrations of γCD.
Figure 6Percentage of inhibition of ascorbic acid in AA/γCD (○) and AA/PVA (●) complexes.
Central composite design for AA/γCD/PVA ternary complexes when concentration of AA was fixed at 0.02 mM.
| Experimental No. | Concentration of γCD (mM) | Concentration of PVA (mM) |
|---|---|---|
| 1 | 5 | 400 |
| 2 | 5 | 100 |
| 3 | 7.5 | 50 |
| 4 | 3 | 250 |
| 5 | 12 | 250 |
| 6 | 7.5 | 250 |
| 7 | 7.5 | 450 |
| 8 | 10 | 100 |
| 9 | 7.5 | 250 |
| 10 | 7.5 | 250 |
| 11 | 7.5 | 250 |
| 12 | 10 | 400 |
| 13 | 7.5 | 250 |
Analysis of variance (ANOVA) of quadratic, two-factor, and linear models for the percentage of inhibition.
| Quadratic Model | Two-Factor Model | Linear Model | ||||
|---|---|---|---|---|---|---|
| Coefficient | Coefficient | Coefficient | ||||
| Model | - | 0.0175 * | - | 0.0153 * | - | 0.0052 * |
| γCD | 1.94 | 0.0015 * | 1.89 | 0.0023 * | 1.89 | 0.0015 * |
| PVA | 0.0277 | 0.9465 | 0.0167 | 0.9723 | 0.0069 | 0.9882 |
| γCD*PVA | −0.4462 | 0.4440 | −0.4482 | 0.5047 | - | - |
| (γCD)2 | −0.5900 | 0.1744 | - | - | - | - |
| (PVA)2 | −0.8360 | 0.0914 ** | - | - | - | - |
| Lack of Fit | - | 0.4871 | - | 0.3241 | - | 0.3660 |
* p-value < 0.05 indicated model or terms were significant at 95% confidential interval. ** p-value < 0.10 indicated model or terms were significant at 90% confidential interval.
Figure 7Contour (a) and surface (b) plots demonstrating relationship between γCD and PVA concentrations on percentage of inhibition.